Background: Vitamin D supplementation is recommended during the first year of life to prevent vitamin D deficiency and rickets, with 400 IU/day commonly recommended in European infants. Vitamin D toxicity is rare but may result in hypercalcaemia, hypercalciuria and renal complications. Although high-dose maternal supplementation during lactation can substantially increase vitamin D concentrations in breast milk, its potential contribution to vitamin D toxicity in the infant remains poorly defined.
Case Presentation: An 11-month-old infant presented with selective food refusal, accepting mainly breast milk, yoghurt and fruit, sleep difficulties and excessive nocturnal sweating. Growth and psychomotor development were age-appropriate. Physical examination revealed a closed anterior fontanelle.
Laboratory evaluation showed elevated ionized calcium (1.39 mmol/L), markedly increased 25-hydroxyvitamin D [25(OH)D] (> 214.1 ng/mL) and suppressed parathyroid hormone (11.2 pg/mL). Bone-specific alkaline phosphatase, thyroid function, urea and creatinine were within age-appropriate reference ranges. In a spot urine sample, the calcium/creatinine ratio was within the normal range (0.44 mg/mg), while the protein/creatinine ratio was elevated (247.8 mg/g). Renal ultrasound showed no abnormalities. Mild iron deficiency without anaemia was also identified.
The combination of markedly elevated 25(OH)D, hypercalcaemia and suppressed PTH supported a diagnosis of probable vitamin D intoxication. A detailed nutritional history revealed that the infant had received 400 IU/day of vitamin D since the first week of life, while the mother had been taking 5000 IU/day of vitamin D continuously since preconception, under nutritional follow-up. No other source of excessive vitamin D intake was identified.
Following discontinuation of vitamin D supplementation, the infant was reassessed three weeks later, showing a slight decrease in ionized calcium (1.33 mmol/L), partial recovery of PTH (11.9 pg/mL) and a decrease in the urinary calcium/creatinine ratio (0.26 mg/mg), despite persistently elevated 25-hydroxyvitamin D levels (>214.1 ng/mL). Calcitonin was also elevated (22.5 pg/mL). Serial biochemical assessments were subsequently performed, with normalization of ionized calcium and PTH for age approximately five months after diagnosis. During follow-up, oral iron supplementation was initiated, with subsequent normalization of ferritin and erythrocyte indices.
Learning Points: Vitamin D toxicity should be considered in infants presenting with hypercalcaemia and suppressed PTH, particularly when accompanied by markedly elevated 25(OH)D levels. Excess vitamin D increases intestinal calcium absorption, resulting in hypercalcaemia and suppression of PTH, with increased urinary calcium excretion.
Although most reported paediatric cases of toxicity are associated with substantial dosing errors or pharmacological doses, maternal high-dose supplementation can significantly increase vitamin D transfer through breast milk. This case highlights the importance of obtaining a detailed maternal and infant supplementation history and considering cumulative sources of vitamin D exposure when investigating infant hypervitaminosis D. Careful monitoring may be warranted when higher-than-standard maternal doses are used during lactation.

